N-((2r,5r)-2-(5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-yl)-5-methyl-1,3-dioxan-5-yl)morpholine-4-carboxamide

ID: ALA5268786

Chembl Id: CHEMBL5268786

Max Phase: Preclinical

Molecular Formula: C24H26FN5O4

Molecular Weight: 467.50

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@]1(NC(=O)N2CCOCC2)CO[C@H](c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)OC1

Standard InChI:  InChI=1S/C24H26FN5O4/c1-24(29-23(31)30-10-12-32-13-11-30)14-33-22(34-15-24)21-27-19(16-2-4-18(25)5-3-16)20(28-21)17-6-8-26-9-7-17/h2-9,22H,10-15H2,1H3,(H,27,28)(H,29,31)/t22-,24-

Standard InChI Key:  VDGCALOJSXKVNQ-HCGLCNNCSA-N

Alternative Forms

  1. Parent:

    ALA5268786

    ---

Associated Targets(Human)

MAPK13 Tchem MAP kinase p38 (1586 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 467.50Molecular Weight (Monoisotopic): 467.1969AlogP: 3.12#Rotatable Bonds: 4
Polar Surface Area: 101.60Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.88CX Basic pKa: 4.15CX LogP: 1.77CX LogD: 1.77
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.61Np Likeness Score: -1.03

References

1. Wu YJ, Meanwell NA..  (2021)  Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design.,  64  (14.0): [PMID:34213340] [10.1021/acs.jmedchem.1c00790]

Source